Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Christian Hansen Holding    CHR   DK0060227585

CHRISTIAN HANSEN HOLDING (CHR)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Chr. Hansen Holding : Announcements from Financière Star 1 S.A. and Novo A/S in accordance with Section 29 of the Danish Securities Trading Act

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/29/2012 | 01:14pm CEST

Hoersholm, 2012-03-29 11:38 CEST (GLOBE NEWSWIRE) --  

Company announcement no.12/2012

Today Chr. Hansen Holding A/S has received major shareholder announcements from Financière Star 1 S.A. and Novo A/S.

According to the announcement from Financière Star 1 S.A., Financière Star 1 S.A. today has sold 35,419,331 shares in Chr. Hansen Holding A/S thus reducing its holdings of shares in Chr. Hansen Holding A/S to 129,442 shares (corresponding to 0.09% of the share capital and voting rights).

According to the announcement from Novo A/S, Novo A/S today has acquired 35,419,331 Chr. Hansen Holding A/S shares and now holds 35,419,331 shares in Chr. Hansen Holding A/S (corresponding to 25.66% of the share capital and voting rights).

The above changes are due to the completion of the share purchase agreement between Financière Star 1 S.A. and Novo A/S announced in company announcement no. 02/2012 of 11 January 2012.

For further information, please contact:

Anders Mohr Christensen, Head of Investor Relations

Tel: +45 4574 7618

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products are centered around cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2010/11 financial year was EUR 636 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,300 dedicated employees in over 30 countries. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.www.chr-hansen.com.

distributed by

This press release was issued by Chr. Hansen Holding A/S and was initially posted at http://investor.chr-hansen.com/releasedetail.cfm?ReleaseID=660271 . It was distributed, unedited and unaltered, by noodls on 2012-03-29 13:06:51 PM. The issuer is solely responsible for the accuracy of the information contained therein.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CHRISTIAN HANSEN HOLDING
06/14CHRISTIAN HANSEN : New starter culture secures mild and creamy soft cheeses
PU
06/13CHRISTIAN HANSEN : Chr. Hansen grows in West Allis
AQ
06/07CHRISTIAN HANSEN : Chr. Hansen and FMC Corporation extend collaboration on natur..
PU
06/01CHRISTIAN HANSEN : Mauricio Graber commences as new CEO of Chr. Hansen Holding A..
AQ
05/23CHRISTIAN HANSEN : New starter culture designed for Mediterranean-style white ch..
PU
05/15CHRISTIAN HANSEN : Chr. Hansen reaches major milestone in innovation pipeline
PU
05/08CHRISTIAN HANSEN : Klaus Bjerrum appointed new EVP of Natural Colors Division
AQ
04/24GLOBAL YEAST INGREDIENTS MARKET 2018 : 9strategy.biz added a depth and professio..
AQ
04/23CHRISTIAN HANSEN : Chr. Hansen expands natural colors capacity
AQ
04/18CHRISTIAN HANSEN : New partnership to develop treatment for peanut allergies
PU
More news
News from SeekingAlpha
04/18Chr. Hansen (CHYHY) Investor Presentation - Slideshow 
04/11CHR Hansen Holding A/S ADR 2018 Q2 - Results - Earnings Call Slides 
01/16CHR Hansen Holding A/S ADR 2018 Q2 - Results - Earnings Call Slides 
Financials (€)
Sales 2018 1 102 M
EBIT 2018 319 M
Net income 2018 231 M
Debt 2018 618 M
Yield 2018 1,51%
P/E ratio 2018 48,31
P/E ratio 2019 41,92
EV / Sales 2018 10,7x
EV / Sales 2019 9,79x
Capitalization 11 170 M
Chart CHRISTIAN HANSEN HOLDING
Duration : Period :
Christian Hansen Holding Technical Analysis Chart | CHR | DK0060227585 | 4-Traders
Technical analysis trends CHRISTIAN HANSEN HOLDING
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 78,1 €
Spread / Average Target -7,8%
EPS Revisions
Managers
NameTitle
Mauricio Graber Chief Executive Officer
Ole Gjessø Andersen Chairman
Søren Westh Lonning Chief Financial Officer & Executive Vice President
Thomas Schäfer Chief Scientific Officer & Executive VP
Frédéric P. Stévenin Independent Director
Sector and Competitors